Skip to main content Accessibility help
×
Home
Hostname: page-component-559fc8cf4f-xbbwl Total loading time: 0.539 Render date: 2021-03-08T04:46:23.591Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Article contents

Korean medication algorithm for depressive disorder (KMAP-DD) 2017: Maintenance treatment

Published online by Cambridge University Press:  23 March 2020

D.I. Jon
Affiliation:
Hallym University Sacred Heart Hospital, Psychiatry, Anyang, Republic of Korea
W. Kim
Affiliation:
Inje University Seoul Baik Hospital, Psychiatry, Seoul, Republic of Korea
H.R. Wang
Affiliation:
The Catholic University St. Mary Hospital, Psychiatry, Seoul, Republic of Korea
Y.S. Woo
Affiliation:
The Catholic University St. Mary Hospital, Psychiatry, Seoul, Republic of Korea
J.S. Seo
Affiliation:
Konkuk University Chungju Hospital, Psychiatry, Chungju, Republic of Korea
Y.M. Park
Affiliation:
Inje University Ilsan Paik Hospital, Psychiatry, Goyang, Republic of Korea
J.H. Jeong
Affiliation:
The Catholic University St. Vincent Hospital, Psychiatry, Suwon, Republic of Korea
S.H. Shim
Affiliation:
Soonchunhyang University Cheonan Hospital, Psychiatry, Cheonan, Republic of Korea
J.G. Lee
Affiliation:
Inje University Haewoondae Baik Hospital, Psychiatry, Busan, Republic of Korea
K.J. Min
Affiliation:
Chung-Ang University Hospital, Psychiatry, Seoul, Republic of Korea
W.M. Bahk
Affiliation:
The Catholic University St. Mary Hospital, Psychiatry, Seoul, Republic of Korea

Abstract

Introduction

The international guideline for treating depression has been widely used.

Objectives

The current study focused on the maintenance treatment section of the third revision of Korean Medication Algorithm for Depressive Disorder (KMAP-DD)

Methods

A 44-item questionnaire was used to obtain the consensus of experts regarding pharmacological treatment strategies for depressive disorder. Of the 144 committee members, 79 psychiatrists responded to the survey. Each treatment strategy or treatment option was evaluated with the nine-point scale.

Results

Most clinicians answered to maintain both antidepressants (AD) and atypical antipsychotics (AAP) for psychotic depression in remission state. The duration of AD maintenance: from 19.8 weeks to 46.8 weeks for patients in remission of the first episode, from 34.8 weeks to 78.4 weeks for the second depressive episode, and long-term continuation for three or more depressive episodes. Aripiprazole was the most preferred AAP. The preferred doses of AD and AAP in maintenance treatment were about 75% and 50% of those in acute treatment The maintenance of AAP in the psychotic depression in remission was similar to the AD, although shorter and less.

Conclusions

The maintenance strategies of KMAP-DD 2017 were similar to those of KMAP-DD 2012. Most clinicians preferred to maintain AD for substantial duration after achieving remission. The maintenance of AAP was also preferred, but the duration was shorter than AD.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster viewing: Cultural psychiatry
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 14 *
View data table for this chart

* Views captured on Cambridge Core between 23rd March 2020 - 8th March 2021. This data will be updated every 24 hours.

Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Korean medication algorithm for depressive disorder (KMAP-DD) 2017: Maintenance treatment
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Korean medication algorithm for depressive disorder (KMAP-DD) 2017: Maintenance treatment
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Korean medication algorithm for depressive disorder (KMAP-DD) 2017: Maintenance treatment
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *